HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Rabascio Selected Research

Bone Marrow Transplantation (Transplantation, Bone Marrow)

2/2012Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Rabascio Research Topics

Disease

11Neoplasms (Cancer)
01/2017 - 09/2003
4Breast Neoplasms (Breast Cancer)
01/2017 - 09/2004
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2015 - 12/2009
2Hematologic Neoplasms (Hematological Malignancy)
08/2012 - 06/2004
2Lymphoma (Lymphomas)
02/2012 - 12/2010
2Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2012 - 06/2002
2Vascular Remodeling
10/2010 - 01/2008
2Colorectal Neoplasms (Colorectal Cancer)
10/2010 - 09/2003
2Neoplasm Metastasis (Metastasis)
05/2010 - 09/2004
1Infections
09/2012
1Autoimmune Diseases (Autoimmune Disease)
09/2012
1Bronchiolitis Obliterans Syndrome
09/2012
1Hodgkin Disease (Hodgkin's Disease)
02/2012
1Multiple Myeloma
02/2012
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2010
1Cardiotoxicity
05/2010
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
05/2010
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2008
1Leukemia
11/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2008
1Hypoxia (Hypoxemia)
01/2008

Drug/Important Bio-Agent (IBA)

3Bevacizumab (Avastin)FDA Link
06/2015 - 09/2003
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2012 - 09/2004
3Pharmaceutical PreparationsIBA
09/2011 - 11/2008
2Proteins (Proteins, Gene)FDA Link
01/2017 - 09/2012
2Capecitabine (Xeloda)FDA Link
06/2015 - 12/2009
2Filgrastim (Neupogen)FDA Link
02/2012 - 12/2010
2Cell-Free Nucleic AcidsIBA
10/2010 - 06/2004
2RNA (Ribonucleic Acid)IBA
10/2010 - 06/2004
2Rituximab (Mabthera)FDA Link
08/2010 - 05/2010
2CladribineFDA LinkGeneric
08/2010 - 05/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2010 - 12/2009
2Angiogenesis InhibitorsIBA
05/2010 - 09/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2004 - 09/2003
1Metalloproteases (Metalloproteinases)IBA
01/2017
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2015
1Tyrosine Kinase InhibitorsIBA
10/2015
1Vinorelbine (Navelbine)FDA LinkGeneric
06/2015
1Viral ProteinsIBA
09/2012
1Immunoglobulin G (IgG)IBA
09/2012
1AntibodiesIBA
09/2012
1Biosimilar PharmaceuticalsIBA
02/2012
1plerixaforFDA Link
02/2012
1Sunitinib (Sutent)FDA Link
09/2011
1pegfilgrastim (Neulasta)FDA Link
12/2010
1Biological ProductsIBA
05/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2009
1Imatinib Mesylate (Gleevec)FDA Link
12/2009
1Biomarkers (Surrogate Marker)IBA
01/2008
1SERPIN-B5 (maspin)IBA
09/2004
1Keratins (Keratin)IBA
09/2004
1Indicators and Reagents (Reagents)IBA
09/2004
1cadherin 5IBA
06/2004
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2004
1Monoclonal AntibodiesIBA
06/2002

Therapy/Procedure

5Drug Therapy (Chemotherapy)
06/2015 - 09/2004
4Therapeutics
06/2015 - 11/2008
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2012
1Colectomy
10/2010
1Transplantation
11/2008
1Blood Component Removal (Apheresis)
09/2004
1Autologous Transplantation
09/2004